HRTX
Heron Therapeuti
0.29$
-0.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -10,484.5% | -553.5% | -247.6% | -85.3% | -208.5% | -235.5% | -136.4% | -46.3% | -15.6% | -17.8% | |
| – | – | 85.9% | 5.0% | 2.0% | 1.4% | 3.2% | 3.5% | 2.7% | 2.3% | 1.7% | 1.5% | |
| – | – | 2,029.4% | 99.3% | 43.1% | 35.2% | 56.7% | 54.3% | 39.9% | 25.9% | 9.0% | 6.7% | |
| – | – | 2,030.1% | 99.4% | 43.2% | 35.3% | 57.6% | 56.1% | 39.5% | – | – | – | |
| – | – | 861.5% | -17.6% | -58.6% | 20.0% | -14.7% | -40.6% | -9.8% | 13.2% | -19.1% | -20.6% | |
| – | – | 245.1% | 8.3% | 11.8% | 4.9% | 7.7% | 3.5% | 1.7% | 1.2% | 1.2% | 0.2% | |
| – | – | 1,163.1% | 25.2% | -359.5% | -14.9% | 235.7% | 37.9% | -3.1% | 14.2% | 13.0% | 10.3% | |
| – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | 582.9% | 1,036.0% | 493.9% | 127.7% | 10.2% | 8.2% | – | – | – | – | |
| – | – | 3,909.3% | -81.3% | -32.3% | 0.0% | 0.0% | 172.5% | 0.0% | 19.2% | 0.0% | -8.2% | |
| – | – | 4,492.2% | 954.7% | 461.6% | 127.7% | 10.3% | 180.7% | 69.7% | 42.6% | 0.7% | 9.3% | |
| – | – | -4,829.2% | 426.3% | -145.5% | 27.4% | 37.5% | -16.9% | -69.8% | 10.5% | -2.0% | 1.8% | |
| – | – | -10,729.6% | -561.8% | -259.4% | -90.2% | -216.2% | -239.0% | -138.1% | -47.5% | -16.8% | -18.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.